Computer Aided Detection Market

Computer Aided Detection Market Study by Mammography, MRI, CT, and Tomosynthesis from 2023 to 2033

Analysis of Computer Aided Detection Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Table of Content

1. Preface

    1.1. Report Scope and Market Segmentation

    1.2. Research Highlights

2. Assumptions and Research Methodology

    2.1. Assumptions and Acronyms Used

    2.2. Research Methodology

3. Executive Summary

    3.1. Global Market Size (US$ Mn) and Forecast, by Region, 2023 and 2027

    3.2. Global Market: Market Snapshot

4. Market Overview

    4.1. Global Market Overview

    4.2. Global Market Key Industry Developments

5. Market Dynamics

    5.1. Drivers and Restraints Snapshot Analysis

    5.2. Drivers

    5.3. Restraints

    5.4. Opportunities

    5.5. Key Trends

    5.6. Global Market Revenue Projections (US$ Mn), 2023–2033

    5.7. Regulatory Framework

    5.8. Heat Map Analysis - Company

6. Global Market Analysis, by Application

    6.1. Introduction

    6.2. Key Insights

    6.3. Global Market Size and Forecast, by Application

        6.3.1. Oncology

            6.3.1.1. Breast Cancer

            6.3.1.2. Lung Cancer

            6.3.1.3. Colorectal Cancer

            6.3.1.4. Prostate Cancer

            6.3.1.5. Liver Cancer

            6.3.1.6. Bone Cancer

            6.3.1.7. Others

        6.3.2. Cardiovascular and Neurological Indications

    6.4. Global Market Analysis, by Application

    6.5. Global Market Attractiveness Analysis, by Application

7. Global Market Analysis, by Imaging Modality

    7.1. Introduction

    7.2. Key Insights

    7.3. Global Market Size and Forecast, by Imaging Modality

        7.3.1. Mammography

        7.3.2. MRI

        7.3.3. Ultrasound Imaging

        7.3.4. Tomosynthesis

        7.3.5. CT

        7.3.6. Others

    7.4. Global Market Analysis, by Imaging Modality

    7.5. Global Market Attractiveness Analysis, by Imaging Modality

8. Global Market Analysis, by Region

    8.1. Introduction

    8.2. Key Insights

    8.3. Global Market Size and Forecast , by Region, 2018–2027

        8.3.1. North America

        8.3.2. Europe

        8.3.3. Asia Pacific

        8.3.4. Latin America

        8.3.5. Middle East & Africa

    8.4. Global Market Analysis, by Region

    8.5. Global Market Attractiveness Analysis, by Region

9. North America Market Analysis

    9.1. North America Market Key Findings

    9.2. North America Market Overview

    9.3. North America Market Size and Forecast, by Application

        9.3.1. Oncology

            9.3.1.1. Breast Cancer

            9.3.1.2. Lung Cancer

            9.3.1.3. Colorectal Cancer

            9.3.1.4. Prostate Cancer

            9.3.1.5. Liver Cancer

            9.3.1.6. Bone Cancer

            9.3.1.7. Others

        9.3.2. Cardiovascular and Neurological Indications

    9.4. North America Market Size and Forecast, by Imaging Modality

        9.4.1. Mammography

        9.4.2. MRI

        9.4.3. Ultrasound Imaging

        9.4.4. Tomosynthesis

        9.4.5. CT

        9.4.6. Others

    9.5. North America Market Forecast, by Country

        9.5.1. U.S.

        9.5.2. Canada

    9.6. North America Market Attractiveness Analysis

        9.6.1. By Application

        9.6.2. By Imaging Modality

        9.6.3. By Country

10. Europe Market Analysis

    10.1. Europe Market Key Findings

    10.2. Europe Market Overview

    10.3. Europe Market Size and Forecast, by Application

        10.3.1. Oncology

            10.3.1.1. Breast Cancer

            10.3.1.2. Lung Cancer

            10.3.1.3. Colorectal Cancer

            10.3.1.4. Prostate Cancer

            10.3.1.5. Liver Cancer

            10.3.1.6. Bone Cancer

            10.3.1.7. Others

        10.3.2. Cardiovascular and Neurological Indications

    10.4. Europe Market Size and Forecast, by Imaging Modality

        10.4.1. Mammography

        10.4.2. MRI

        10.4.3. Ultrasound Imaging

        10.4.4. Tomosynthesis

        10.4.5. CT

        10.4.6. Others

    10.5. Europe Market Forecast, by Country

        10.5.1. Germany

        10.5.2. U.K.

        10.5.3. France

        10.5.4. Spain

        10.5.5. Italy

        10.5.6. Rest of Europe

    10.6. Europe Market Attractiveness Analysis

        10.6.1. By Application

        10.6.2. By Imaging Modality

        10.6.3. By Country

11. Asia Pacific Market Analysis

    11.1. Asia Pacific Market Key Findings

    11.2. Asia Pacific Market Overview

    11.3. Asia Pacific Cytometry Market Size and Forecast, by Application

        11.3.1. Oncology

            11.3.1.1. Breast Cancer

            11.3.1.2. Lung Cancer

            11.3.1.3. Colorectal Cancer

            11.3.1.4. Prostate Cancer

            11.3.1.5. Liver Cancer

            11.3.1.6. Bone Cancer

            11.3.1.7. Others

        11.3.2. Cardiovascular and Neurological Indications

    11.4. Asia Pacific Market Size and Forecast, by Imaging Modality

        11.4.1. Mammography

        11.4.2. MRI

        11.4.3. Ultrasound Imaging

        11.4.4. Tomosynthesis

        11.4.5. CT

        11.4.6. Others

    11.5. Asia Pacific Market Forecast, by Country

        11.5.1. China

        11.5.2. India

        11.5.3. Japan

        11.5.4. Australia & New Zealand

        11.5.5. Rest of Asia Pacific

    11.6. Asia Pacific Market Attractiveness Analysis

        11.6.1. By Application

        11.6.2. By Imaging Modality

        11.6.3. By Country

12. Latin America Market Analysis

    12.1. Latin America Market Key Findings

    12.2. Latin America Market Overview

    12.3. Latin America Cytometry Market Size and Forecast, by Application

        12.3.1. Oncology

            12.3.1.1. Breast Cancer

            12.3.1.2. Lung Cancer

            12.3.1.3. Colorectal Cancer

            12.3.1.4. Prostate Cancer

            12.3.1.5. Liver Cancer

            12.3.1.6. Bone Cancer

            12.3.1.7. Others

        12.3.2. Cardiovascular and Neurological Indications

    12.4. Latin America Market Size and Forecast, by Imaging Modality

        12.4.1. Mammography

        12.4.2. MRI

        12.4.3. Ultrasound Imaging

        12.4.4. Tomosynthesis

        12.4.5. CT

        12.4.6. Others

    12.5. Latin America Market Forecast, by Country

        12.5.1. Brazil

        12.5.2. Mexico

        12.5.3. Rest of Latin America

    12.6. Latin America Market Attractiveness Analysis

        12.6.1. By Application

        12.6.2. By Imaging Modality

        12.6.3. By Country

13. Middle East & Africa Market Analysis

    13.1. Middle East & Africa Market Key Findings

    13.2. Middle East & Africa Market Overview

    13.3. Middle East & Africa Cytometry Market Size and Forecast, by Application

        13.3.1. Oncology

            13.3.1.1. Breast Cancer

            13.3.1.2. Lung Cancer

            13.3.1.3. Colorectal Cancer

            13.3.1.4. Prostate Cancer

            13.3.1.5. Liver Cancer

            13.3.1.6. Bone Cancer

            13.3.1.7. Others

        13.3.2. Cardiovascular and Neurological Indications

    13.4. Middle East & Africa Market Size and Forecast, by Imaging Modality

        13.4.1. Mammography

        13.4.2. MRI

        13.4.3. Ultrasound Imaging

        13.4.4. Tomosynthesis

        13.4.5. CT

        13.4.6. Others

    13.5. Middle East Market Forecast, by Country

        13.5.1. South Africa

        13.5.2. Saudi Arabia

        13.5.3. U.A.E.

        13.5.4. Rest of Middle East & Africa

    13.6. Middle East Market Attractiveness Analysis

        13.6.1. By Application

        13.6.2. By Imaging Modality

        13.6.3. By Country

14. Competition Landscape

    14.1. Global Market Share Analysis, by Company (2018)

    14.2. Company Profiles

        14.2.1. Agfa-Gevaert N.V.

            14.2.1.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.1.2. Financials

            14.2.1.3. Recent Developments

            14.2.1.4. Strategy

        14.2.2. Fujifilm Holdings Corporation

            14.2.2.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.2.2. Financials

            14.2.2.3. Recent Developments

            14.2.2.4. Strategy

        14.2.3. Hologic, Inc.

            14.2.3.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.3.2. Financials

            14.2.3.3. Recent Developments

            14.2.3.4. Strategy

        14.2.4. iCAD, Inc.

            14.2.4.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.4.2. Financials

            14.2.4.3. Recent Developments

            14.2.4.4. Strategy

        14.2.5. Koninklijke Philips N.V.

            14.2.5.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.5.2. Financials

            14.2.5.3. Recent Developments

            14.2.5.4. Strategy

        14.2.6. Siemens Healthineers

            14.2.6.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.6.2. Financials

            14.2.6.3. Recent Developments

            14.2.6.4. Strategy

        14.2.7. Toshiba Medical Systems Corporation

            14.2.7.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.7.2. Financials

            14.2.7.3. Recent Developments

            14.2.7.4. Strategy

        14.2.8. GE Healthcare

            14.2.8.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.8.2. Financials

            14.2.8.3. Recent Developments

            14.2.8.4. Strategy

        14.2.9. Samsung Medison Co. Ltd.

            14.2.9.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.9.2. Financials

            14.2.9.3. Recent Developments

            14.2.9.4. Strategy

        14.2.10. Hitachi Medical Corporation (Hitachi, Ltd.)

            14.2.10.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.10.2. Financials

            14.2.10.3. Recent Developments

            14.2.10.4. Strategy

        14.2.11. Invivo Corporation

            14.2.11.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.11.2. Financials

            14.2.11.3. Recent Developments

            14.2.11.4. Strategy

        14.2.12. McKesson Corporation

            14.2.12.1. Overview (HQ, Employee Strength, Business Segments)

            14.2.12.2. Financials

            14.2.12.3. Recent Developments

            14.2.12.4. Strategy

Don't Need a Global Report?

save 40%! on Country & Region specific reports

List Of Table

Table 1: Global Market Size (US$ Mn) Analysis, by Application, 2018–2022

Table 2: Global Market Size (US$ Mn) Forecast, by Application, 2023–2033

Table 3: Global Market Size (US$ Mn) Analysis, by Oncology, 2018–2022

Table 4: Global Market Size (US$ Mn) Forecast, by Oncology, 2023–2033

Table 5: Global Market Size (US$ Mn) Analysis, by Cardiovascular and Neurological Indications, 2018–2022

Table 6: Global Market Size (US$ Mn) Forecast, by Cardiovascular and Neurological Indications, 2023–2033

Table 7: Global Market Size (US$ Mn) Analysis, by Imaging Modality, 2018–2022

Table 8: Global Market Size (US$ Mn) Forecast, by Imaging Modality, 2023–2033

Table 9: Global Market Size (US$ Mn) Analysis, by Mammography, 2018–2022

Table 10: Global Market Size (US$ Mn) Forecast, by Mammography, 2023–2033

Table 11: Global Market Size (US$ Mn) Analysis, by MRI, 2018–2022

Table 12: Global Market Size (US$ Mn) Forecast, by MRI, 2023–2033

Table 13: Global Market Size (US$ Mn) Analysis, by Ultrasound Imaging, 2018–2022

Table 14: Global Market Size (US$ Mn) Forecast, by Ultrasound Imaging, 2023–2033

Table 15: Global Market Size (US$ Mn) Analysis, by Tomosynthesis, 2018–2022

Table 16: Global Market Size (US$ Mn) Forecast, by Tomosynthesis, 2023–2033

Table 17: Global Market Size (US$ Mn) Analysis, by CT, 2018–2022

Table 18: Global Market Size (US$ Mn) Forecast, by CT, 2023–2033

Table 19: Global Market Size (US$ Mn) Analysis, by Others, 2018–2022

Table 20: Global Market Size (US$ Mn) Forecast, by Others, 2023–2033

Table 21: Global Market Size (US$ Mn) Analysis, by Region, 2018–2022

Table 22: Global Market Size (US$ Mn) Forecast, by Region, 2023–2033

Table 23: North America Market Size (US$ Mn) Analysis, by Application, 2018–2022

Table 24: North America Market Size (US$ Mn) Forecast, by Application, 2023–2033

Table 25: North America Market Size (US$ Mn) Analysis, by Imaging Modality, 2018–2022

Table 26: North America Market Size (US$ Mn) Forecast, by Imaging Modality, 2023–2033

Table 27: North America Market Size (US$ Mn) Analysis, by Country, 2018–2022

Table 28: North America Market Size (US$ Mn) Forecast, by Country, 2023–2033

Table 29: Europe Market Size (US$ Mn) Analysis, by Application, 2018–2022

Table 30: Europe Market Size (US$ Mn) Forecast, by Application, 2023–2033

Table 31: Europe Market Size (US$ Mn) Analysis, by Imaging Modality, 2018–2022

Table 32: Europe Market Size (US$ Mn) Forecast, by Imaging Modality, 2023–2033

Table 33: Europe Market Size (US$ Mn) Analysis, by Country, 2018–2022

Table 34: Europe Market Size (US$ Mn) Forecast, by Country, 2023–2033

Table 35: Asia Pacific Market Size (US$ Mn) Analysis, by Application, 2018–2022

Table 36: Asia Pacific Market Size (US$ Mn) Forecast, by Application, 2023–2033

Table 37: Asia Pacific Market Size (US$ Mn) Analysis, by Imaging Modality, 2018–2022

Table 38: Asia Pacific Market Size (US$ Mn) Forecast, by Imaging Modality, 2023–2033

Table 39: Asia Pacific Market Size (US$ Mn) Analysis, by Country, 2018–2022

Table 40: Asia Pacific Market Size (US$ Mn) Forecast, by Country, 2023–2033

Table 41: Latin America Market Size (US$ Mn) Analysis, by Application, 2018–2022

Table 42: Latin America Market Size (US$ Mn) Forecast, by Application, 2023–2033

Table 43: Latin America Market Size (US$ Mn) Analysis, by Imaging Modality, 2018–2022

Table 44: Latin America Market Size (US$ Mn) Forecast, by Imaging Modality, 2023–2033

Table 45: Latin America Market Size (US$ Mn) Analysis, by Country, 2018–2022

Table 46: Latin America Market Size (US$ Mn) Forecast, by Country, 2023–2033

Table 47: MEA Market Size (US$ Mn) Analysis, by Application, 2018–2022

Table 48: MEA Market Size (US$ Mn) Forecast, by Application, 2023–2033

Table 49: MEA Market Size (US$ Mn) Analysis, by Imaging Modality, 2018–2022

Table 50: MEA Market Size (US$ Mn) Forecast, by Imaging Modality, 2023–2033

Table 51: MEA Market Size (US$ Mn) Analysis, by Country, 2018–2022

Table 52: MEA Market Size (US$ Mn) Forecast, by Country, 2023–2033

Table 53: U.S. Market Size (US$ Mn), 2023-2033

Table 54: Canada Market Size (US$ Mn), 2023-2033

Table 55: Brazil Market Size (US$ Mn), 2023-2033

Table 56: Mexico Market Size (US$ Mn), 2023-2033

Table 57: Argentina Market Size (US$ Mn), 2023-2033

Table 58: Germany Market Size (US$ Mn), 2023-2033

Table 59: France Market Size (US$ Mn), 2023-2033

Table 60: Italy Market Size (US$ Mn), 2023-2033

Table 61: Spain Market Size (US$ Mn), 2023-2033

Table 62: U.K. Market Size (US$ Mn), 2023-2033

Table 63: Benelux Market Size (US$ Mn), 2023-2033

Table 64: Russia Market Size (US$ Mn), 2023-2033

Table 65: China Market Size (US$ Mn), 2023-2033

Table 66: Japan Market Size (US$ Mn), 2023-2033

Table 67: South Korea Market Size (US$ Mn), 2023-2033

Table 68: India Market Size (US$ Mn), 2023-2033

Table 69: Thailand Market Size (US$ Mn), 2023-2033

Table 70: Indonesia Market Size (US$ Mn), 2023-2033

Table 71: Malaysia Market Size (US$ Mn), 2023-2033

Table 72: Australia & New Zealand Market Size (US$ Mn), 2023-2033

Table 73: GCC Countries Market Size (US$ Mn), 2023-2033

Table 74: Egypt Market Size (US$ Mn), 2023-2033

Table 75: South Africa Market Size (US$ Mn), 2023-2033

Table 76: Turkey Market Size (US$ Mn), 2023-2033

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

List Of Figures

Figure 01: Global Market Snapshot

Figure 02: Global Market Size (US$ Mn) and Distribution by Geography, 2023 and 2033

Figure 03: Global Market Size (US$ Mn) Forecast, 2023–2033

Figure 04: Global Market - Revenue Share by Application, 2018

Figure 05: Global Market - Revenue Share by Imaging Modality, 2018

Figure 07: Market Share Analysis By Imaging Modality (2018)

Figure 06: Market Share Analysis By Application (2018)

Figure 08: Market Share Analysis By Region (2018)

Figure 09: Global Market Value Share Analysis, by Application, 2023 and 2033

Figure 10: Global Market Attractiveness Analysis, by Application, 2023–2033

Figure 11: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oncology, 2023–2033

Figure 12: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cardiovascular and Neurological Indications, 2023–2033

Figure 13: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Breast Cancer, 2023–2033

Figure 14: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Lung Cancer, 2023–2033

Figure 15: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Colorectal Cancer, 2023–2033

Figure 16: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Prostate Cancer, 2023–2033

Figure 17: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Liver Cancer, 2023–2033

Figure 18: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Bone Cancer, 2023–2033

Figure 19: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2023–2033

Figure 20: Global Market Value Share Analysis, by Imaging Modality, 2023 and 2033

Figure 21: Global Market Attractiveness Analysis, by Imaging Modality, 2023–2033

Figure 22: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Mammography, 2023–2033

Figure 23: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by MRI, 2023–2033

Figure 24: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ultrasound Imaging, 2023–2033

Figure 25: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Tomosynthesis, 2023–2033

Figure 26: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by CT, 2023–2033

Figure 27: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2023–2033

Figure 28: Global Market Value Share Analysis, by Region, 2023 and 2033

Figure 29: Global Market Attractiveness Analysis, by Region, 2023–2033

Figure 30: North America Computer Aided Detection Market Size (US$ Mn) Forecast, 2023–2033

Figure 31: North America Market Value Share Analysis, by Application, 2023 and 2033

Figure 32: North America Market Attractiveness Analysis, by Application, 2023-2033

Figure 33: North America Computer Aided Detection Market Value Share Analysis, by Imaging Modality, 2023 and 2033

Figure 34: North America Computer Aided Detection Market Attractiveness Analysis, by Imaging Modality, 2023-2033

Figure 35: North America Market Value Share Analysis, by Country, 2023 and 2033

Figure 36: North America Market Attractiveness Analysis, by Country, 2023-2033

Figure 37: Europe Computer Aided Detection Market Size (US$ Mn) Forecast, 2023–2033

Figure 38: Europe Market Value Share Analysis, by Application, 2023 and 2033

Figure 39: Europe Market Attractiveness Analysis, by Application, 2023–2033

Figure 40: Europe Computer Aided Detection Market Value Share Analysis, by Imaging Modality, 2023 and 2033

Figure 41: Europe Computer Aided Detection Market Attractiveness Analysis, by Imaging Modality, 2023–2033

Figure 42: Europe Market Value Share Analysis, by Country/Sub-region, 2023 and 2033

Figure 43: Europe Market Attractiveness Analysis, by Country/Sub-region, 2023–2033

Figure 44: Asia Pacific Market Size (US$ Mn) Forecast, 2023–2033

Figure 45: Asia Pacific Market Value Share Analysis, by Application, 2023 and 2033

Figure 46: Asia Pacific Market Attractiveness Analysis, by Application, 2023–2033

Figure 47: Asia Pacific Market Value Share Analysis, by Imaging Modality, 2023 and 2033

Figure 48: Asia Pacific Market Attractiveness Analysis, by Imaging Modality, 2023–2033

Figure 49: Asia Pacific Market Value Share Analysis, by Country/Sub-region, 2023 and 2033

Figure 50: Asia Pacific Market Attractiveness Analysis, by Country/Sub-region, 2023–2033

Figure 51: Latin America Market Size (US$ Mn) Forecast, 2023–2033

Figure 52: Latin America Market Value Share Analysis, by Application, 2023 and 2033

Figure 53: Latin America Market Attractiveness Analysis, by Application, 2023–2033

Figure 54: Latin America Market Value Share Analysis, by Imaging Modality, 2023 and 2033

Figure 55: Latin America Market Attractiveness Analysis, by Imaging Modality, 2023–2033

Figure 56: Latin America Market Value Share Analysis, by Country/Sub-region, 2023 and 2033

Figure 57: Latin America Market Attractiveness Analysis, by Country/Sub-region, 2023–2033

Figure 58: Middle East & Africa Market Size (US$ Mn) Forecast, 2023–2033

Figure 59: Middle East & Africa Market Value Share Analysis, by Application, 2023 and 2033

Figure 60: Middle East & Africa Market Attractiveness Analysis, by Application, 2023–2033

Figure 61: Middle East & Africa Market Value Share Analysis, by Imaging Modality, 2023 and 2033

Figure 62: Middle East & Africa Market Attractiveness Analysis, by Imaging Modality, 2023–2033

Figure 63: Middle East & Africa Market Value Share Analysis, by Country/Sub-region, 2023 and 2033

Figure 64: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region, 2023–2033

Figure 65: Global Market Share, by Company, 2018

Figure 66: Agfa-Gevaert N.V., Revenue (US$ Mn) & Y-o-Y Growth (%), 2018–2018

Figure 67: Agfa-Gevaert N.V., Breakdown of Net Sales (%), by Business Segment, 2018

Figure 68: Agfa-Gevaert N.V., Breakdown of Net Sales (%), by Region, 2018

Figure 69: Fujifilm Holdings Corporation, Revenue (US$ Mn) & Y-o-Y Growth (%), 2018–2018

Figure 70: Fujifilm Holdings Corporation, Breakdown of Net Sales (%), by Region, 2018

Figure 71: Fujifilm Holdings Corporation, Breakdown of Net Sales (%), by Business Segment, 2018

Figure 72: Hologic, Inc., Revenue (US$ Mn) & Y-o-Y Growth (%), 2018–2018

Figure 73: Hologic, Inc., Breakdown of Net Sales (%), by Business Segment, 2018

Figure 74: Hologic, Inc., Breakdown of Net Sales (%), by Region, 2018

Figure 75: iCAD, Inc., Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018

Figure 76: iCAD, Inc., Breakdown of Net Sales (%), by Business Segment, 2018

Figure 77: iCAD, Inc., Breakdown of Net Sales (%), by Region, 2018

Figure 78: Koninklijke Philips N.V., Revenue (US$ Mn) & Y-o-Y Growth (%), 2018–2022

Figure 79: Koninklijke Philips N.V., Breakdown of Net Sales (%), by Business Segment, 2018

Figure 80: Koninklijke Philips N.V., Breakdown of Net Sales (%), by Region, 2017

Figure 81: Siemens Healthineers, Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2022

Figure 82: Siemens Healthineers, Breakdown of Net Sales (%), by Business Segment, 2018

Figure 83: Siemens Healthineers, Breakdown of Net Sales (%), by Region, 2018

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Computer Aided Detection Market

Schedule a Call